Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Massachusetts General Hospital Hope for Depression Research Foundation |
---|---|
Information provided by: | Massachusetts General Hospital |
ClinicalTrials.gov Identifier: | NCT00812227 |
The purpose of this study is to see whether we can predict which patients with depression will get better when we treat them with psychodynamic psychotherapy. We will use neuroimaging (a method of looking at brain activity) in this study. We want to see whether there are changes in the brains of patients receiving this type of therapy. We hypothesize that these changes may predict how well certain parts of the psychotherapy treatment process works.
Condition | Intervention |
---|---|
Major Depressive Disorder |
Behavioral: Psychodynamic Psychotherapy |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Single Group Assignment |
Official Title: | Neural Correlates of Psychodynamic Psychotherapy for Depression |
Estimated Enrollment: | 45 |
Study Start Date: | August 2008 |
Estimated Primary Completion Date: | August 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Psychodynamic psychotherapy: Experimental |
Behavioral: Psychodynamic Psychotherapy
Screened and eligible patients will receive 16 individual sessions of psychodynamic psychotherapy, each lasting 45-50 minutes.
|
In this study, we will treat patients with brief psychodynamic psychotherapy. Psychodynamic psychotherapy is a type of treatment that may be as helpful as medications in treating depression. It focuses on thoughts, feelings, and behaviors as well as both current and past relationships. Psychotherapy explores better ways of coping with feelings, expressing needs, and interacting with others in order to cope with depression and other life problems. Subjects will go to 16 weekly, 45-minute, individual sessions of psychodynamic psychotherapy over the course of the study. At five times throughout the study, subjects will come in for extra visits, which last approximately 1.5 hours and which include: speaking with a study doctor about depressive symptoms, filling out extra questionnaires, and performing a Quantitative Electroencephalogram (QEEG). The QEEG is a machine that measures the electrical activity of the brain. This task will take approximately 15 minutes.
Subjects will also have the opportunity to participate in an additional positron emission tomography (PET) component of the study, for which additional compensation will be made based on the time commitment.
Ages Eligible for Study: | 18 Years to 55 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Sarah E Chuzi, BA | (617)724-3520 | schuzi@partners.org |
United States, Massachusetts | |
Depression Clinical and Research Program | Recruiting |
Boston, Massachusetts, United States, 02114 | |
Contact: Sarah E Chuzi, BA 617-724-3520 schuzi@partners.org | |
Principal Investigator: Joshua Roffman, MD | |
Principal Investigator: Janet Witte, MD, MPH |
Principal Investigator: | Joshua Roffman, MD | Massachusetts General Hospital Department of Psychiatry |
Principal Investigator: | Janet Witte, MD, MPH | Massachusetts General Hospital Department of Psychiatry |
Responsible Party: | Massachusetts General Hospital Department of Psychiatry ( Joshua Roffman, MD ) |
Study ID Numbers: | 2008-P-001181 |
Study First Received: | December 18, 2008 |
Last Updated: | December 19, 2008 |
ClinicalTrials.gov Identifier: | NCT00812227 |
Health Authority: | United States: Institutional Review Board |
Depression Psychotherapy Neuroimaging Subjects with Major Depressive Disorder (MDD) |
Depression Mental Disorders Mood Disorders |
Depressive Disorder, Major Depressive Disorder Behavioral Symptoms |